Haim Zaltzman > Latham & Watkins LLP > San Francisco, United States > Lawyer Profile

Latham & Watkins LLP
505 MONTGOMERY STREET
SUITE 2000
SAN FRANCISCO, CA 94111-6538
CALIFORNIA
United States

Position

Haim Zaltzman, Global Vice Chair of Latham’s Emerging Companies & Growth Practice, focuses on private capital, finance, and other corporate transactions, primarily in the healthcare, life sciences, and technology fields. Haim is a member of the firm’s Strategic Client Committee and Private Capital Practice.

Haim frequently represents borrowers/issuers, sponsors, and financial institutions in private capital transactions, including:

    • Technology growth financings (venture, structured, ABL, ARR, CARR/bookings, milestone-based, Up C, SPAC-related, and other structures)
    • Direct lending transactions (private equity acquisition financings, cash-flow, ARR, CARR, liquidity, and other structures)
    • Life sciences intellectual property monetization transactions (IP-backed debt, royalty buyout, synthetic royalty, revenue participations, R&D financings)
    • Leasing, crypto/bitcoin, securitization, and other similar asset-based transactions
    • Structured equity, pre-IPO debt and equity financings, and similar private capital transactions

Haim holds leadership positions with the Chinese American International School and the American Jewish Committee.

Haim has also been featured on CNBC, The Information, Bloomberg, The Washington Post, CFO Magazine, The Recorder, Law360.comThe Daily Journal, the International Financial Law Review, and VCExperts.com for his debt experience.

Lawyer Rankings

United States > M&A/corporate and commercial > Venture capital and emerging companies

Favored for its ability to utilize its premier technology and life sciences offerings, Latham & Watkins LLP’s emerging companies and venture capital practice acts for an array of start-ups and growth companies on formations through to funding and exit transactions. The team also represents venture capital funds and other financial institutions on investment and exit strategies. In Silicon Valley, emerging companies chair Benjamin Potter is the key contact for a raft of start-up technology, fintech, healthcare, and life sciences clients; he recently advised Eigen Labs on its $100m Series B financing. Rounding out the lead partners are global department vice chairs Brian Patterson, who sits in San Francisco, and Haim Zaltzman, who splits his time between New York, San Francisco and Silicon Valley. In Century City, Alex Voxman is equipped to advise emerging companies and venture capital funds on the full suite of corporate, M&A, and financing matters, while in Boston Stephen Ranere specializes in venture capital and corporate transactions in the technology and life sciences sectors. Also in Boston, John Chory handles both company formations and subsequent IPOs. The group was boosted in 2024 by the hire of three new partners in San Francisco: duo Seth Gottlieb and Alex Kassai joined from Cooley LLP, while Zachary Fallon joined from technology-focused firm, Ketsal.